Literature DB >> 26001227

Evolving Early Lung Cancers Detected During Follow-Up of Idiopathic Interstitial Pneumonia: Serial CT Features.

Sang Young Oh1, Mi Young Kim, Ji-Eun Kim, Sung-Soo Kim, Tai Sun Park, Dong Soon Kim, Chang-Min Choi.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the CT characteristics of newly developed lung cancer on CT studies obtained during follow-up of idiopathic interstitial pneumonia (IIP) before the appearance of identifiable tumors to the time of detectable lung cancer and thereafter.
MATERIALS AND METHODS: The study sample included 66 cancers diagnosed in 63 patients with IIP and lung cancer (59 men, four women; median age, 64 years; range, 40-85 years) between October 1998 and July 2012. Two radiologists independently reviewed 193 CT scans, determined the earliest presence of cancer and IIP, and evaluated tumor size, lobar and axial location, shape, and tumor density. Delay in clinical diagnosis and doubling time were measured with first and second follow-up CT examinations.
RESULTS: Interobserver agreement was good (κ > 0.77). The median tumor size was 17 mm (range, 5-30 mm) for the 46 T1a and 20 T1b cancers. Most of the tumors (42 [63.6%]) were located in the lower lobes. Thirty-five tumors (53.0%) were at the interface between fibrotic cyst and normal lung, and 21 (31.8%) were in the midst of fibrotic lung cysts. Most of the tumors had a round or oval shape (52 [78.8%]) and were solid (62 [93.9%]). The median delay in diagnosis was 46 days (range, 8-760 days). The first median doubling time was 77 days (range, 15-525 days), and the second was 53 days (27-248).
CONCLUSION: New lung cancers during CT follow-up of IIP usually appear as small solid nodules with a round or oval shape. Most cancers are located at the interface between fibrotic cyst and normal lung or in the midst of fibrotic cysts of the lower lobes of subpleural lung.

Entities:  

Keywords:  MDCT; early cancer detection; follow-up studies; idiopathic pulmonary fibrosis; interstitial; lung disease; lung neoplasms

Mesh:

Year:  2015        PMID: 26001227     DOI: 10.2214/AJR.14.13587

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

Review 1.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Volume doubling time of lung cancer detected in idiopathic interstitial pneumonia: comparison with that in chronic obstructive pulmonary disease.

Authors:  Cherry Kim; Sang Min Lee; Jooae Choe; Eun Jin Chae; Kyung-Hyun Do; Joon Beom Seo
Journal:  Eur Radiol       Date:  2017-10-16       Impact factor: 5.315

Review 3.  Idiopathic pulmonary fibrosis: the radiologist's role in making the diagnosis.

Authors:  Michael P Mohning; John Caleb Richards; Tristan J Huie
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

4.  Diagnostic usefulness of bronchoscopy for peripheral pulmonary lesions in patients with idiopathic pulmonary fibrosis.

Authors:  Hitomi Nogawa; Yuji Matsumoto; Midori Tanaka; Takaaki Tsuchida
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 3.005

Review 5.  Spectrum of early lung cancer presentation in low-dose screening CT: a pictorial review.

Authors:  Cristiano Rampinelli; Sonia Francesca Calloni; Marta Minotti; Massimo Bellomi
Journal:  Insights Imaging       Date:  2016-05-17

Review 6.  Imaging Review of the Lung Parenchymal Complications in Patients with IPF.

Authors:  Elisa Baratella; Ilaria Fiorese; Cristina Marrocchio; Francesco Salton; Maria Assunta Cova
Journal:  Medicina (Kaunas)       Date:  2019-09-20       Impact factor: 2.430

7.  Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia.

Authors:  Kazumasa Ogawa; Hironori Uruga; Takeshi Fujii; Sakashi Fujimori; Tadasu Kohno; Atsuko Kurosaki; Kazuma Kishi; Shinji Abe
Journal:  BMC Pulm Med       Date:  2020-11-20       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.